Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for KRYAF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for KRYAF and 80,000+ other tickers.
See exactly how KRYAF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for KRYAF and 80,000+ other tickers.
Kerry Group plc, along with its subsidiaries, is a global provider of advanced taste and nutritional solutions. These offerings serve the food, beverage, and pharmaceutical industries across extensive geographical territories including Europe, the Middle East, Africa, the Americas, and the Asia Pacific region. The company's operations are divided into two main segments: Taste & Nutrition, and Consumer Foods. The Taste & Nutrition division focuses on developing and supplying innovative technologies and ingredients to enhance flavor, nutritional content, and functional properties for clients in…
Kerry Group plc (KRYAY) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Kerry Group plc (KRYAY) Q4 2025 Earnings Call Transcript
Kerry Group shares have declined 20% despite robust performance, with expanding EBITDA margins and reaffirmed 2025 and 2028 targets. KRYAY reported strong H1 2025 results: revenue up 1.5%, EBITDA up 7%, and free cash flow per share at €2.21, supporting a new €300 million buyback. Management maintains guidance for 7%-11% adjusted EPS growth in 2025, with margin expansion and regional volume growth showing mixed trends.
Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo. On the positive side, the three new purchases we made in Q2 during the post-Liberation Day market meltdown—Lam Research, ASML and Thermo Fisher Scientific—were each among our top contributors to returns in Q3. Our top contributor in Q3 was Alphabet, a long-time holding.
Kerry Group plc (OTCPK:KRYAY) Q3 2025 Earnings Call October 23, 2025 3:00 AM EDT Company Participants William Lynch - Head of Investor Relations Edmond Scanlon - Group CEO & Executive Director Marguerite Larkin - CFO & Executive Director Conference Call Participants Patrick Higgins - Goodbody Stockbrokers UC, Research Division Alexander Sloane - Barclays Bank PLC, Research Division Edward Hockin - JPMorgan Chase & Co, Research Division Fulvio Cazzol - Joh. Berenberg, Gossler & Co. KG, Research Division Cathal Kenny - Davy, Research Division Presentation Operator Good morning, and thank you for standing by.